CR-064

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCR-064
Drug Alias NameCR-064
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAngiopoietin-related protein 4 inhibitors
TargetsAngiopoietin-related protein 4
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCuraGen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuraGen Corp
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A